The advertisement promotes the Oncodetect™ Molecular Residual Disease test by Exact Sciences, highlighting its purpose in detecting signs of cancer.
Creative Information
| CID: | d8eeace8-ad7e-4d32-a598-d646f2416836 |
| CRID: | 92_2966:477288 |
| Domain: | exactsciences.com |
| Seat: | RBC |
| Size: | 300x250 |
| Bid: | $1.42 |
| Timestamp: | 11/4/2025, 4:20:03 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 5:41:06 PM | 6.10s | |
| adomain_analysis | success | 11/4/2025, 5:41:21 PM | 4.10s | |
| adomain_capture | success | 11/4/2025, 5:40:42 PM | 0.22s | |
| ad_render | success | 11/4/2025, 5:41:00 PM | 18.09s | |
| brand_mapping | success | 11/4/2025, 4:20:03 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: Exact Sciences
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 513.18 KB | ||||||||||||||||||||||
| Render Time: | 8.86 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 532.27 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<div data-rp-type="trp-display-creative" data-rp-impression-id="09b968b2-f9c9-4325-afb3-2798a8f58630" data-rp-aqid="2966:477288" data-rp-acct-id="11864"><div style="width: 0; height: 0; overflow: hidden;"><img border="0" width="1" height="1" src="https://rtb.adentifi.com/Wins?price=926102DC0AEB5EDF;impId=1;lId=100045;sId=760013;cId=18671;crId=477288;adExchange=Rubicon;engineId=i-03fda3c330ecba81f;adThdId=2e6accf955843ec576534c31d6948918;property=m.imdb.com;dIp=MTcyLjU2LjIyMC4xNTM;dIpv6=;dealId=0;geoId=9837;inventoryId=273233;rtdmIndicator=1;isDoubleVerify=false;timestamp=1761665596;bidPrice=MS44MQ;transactCurr=1;transactConvRate=1.0;agencyCurr=1;agencyConvRate=1.0;billCurr=1;billConvRate=1.0;crRt=1;adId=6c8725a0-b413-11f0-9211-12126ea64771" alt="" /><img border="0" width="1" height="1" src="https://beacon-iad2.rubiconproject.com/beacon/d/09b968b2-f9c9-4325-afb3-2798a8f58630?oo=0&accountId=11864&siteId=229562&zoneId=1708178&sizeId=15&e=6A1E40E384DA563B214588976D48FCFCBDA91C63A4E1A5337FACC4A1F1B8213F3F0F1A608BECECEA72C14598AC6E92303AEF6080AA10EA77A0A0901FCAFF21EEAE9916C7525F32275FC5B167DD54DF0FC0D074DDB4164592F434579CEE14D35818858AE0A09F85C22D8585E071F06738D97D35FE0FBEAD40CC8F07C33F76E5ADDB36492CD3B0E635518DD6137AAECB6C5848F04E58591287275E555E0FF232D9BAD96C209AF5F671D1371C40B8F2C52B6D5CF763BA2286E0" alt="" /></div>
<script src="mraid.js"></script><div id="adthContainer477288" style="position:relative"></div><script> at_custom = { adWidth: "300px", adHeight: "250px", ifrmsrc: "https://adtheorent-html5-ads.s3.amazonaws.com/84a4695f-b92d-4872-865b-8b1301f6da6f/300x250_Banner_2/index.html?zip=19104&lat=0.0&lng=0.0&temperature=45", divuniq: "477288", ctu: "https://rtb.adentifi.com/Clicks?crId=477288;sId=760013;lId=100045;cId=18671;adExchange=Rubicon;action=click;adId=6c8725a0-b413-11f0-9211-12126ea64771;adThdId=2e6accf955843ec576534c31d6948918;engineId=i-03fda3c330ecba81f;dIp=MTcyLjU2LjIyMC4xNTM;dIpv6=;adThdIdCode=WEB_MD5_V4;dealId=0;geoId=9837;inventoryId=273233;rtdmIndicator=1;timestamp=1761665596;lat=MC4w;long=MC4w;dma=NTA0;stateCode=;zip=MTkxMDQ;redir=" };</script><script src = "https://ads.adtheorent.com/js/atadserv.js"></script><noscript> <div id="adthContainer477288" style="width:300px;height:250px;position:relative;"> <iframe width="300px" height="250px" frameborder="0" id="atifrm" src="https://adtheorent-html5-ads.s3.amazonaws.com/84a4695f-b92d-4872-865b-8b1301f6da6f/300x250_Banner_2/index.html" style="width: 300px; height: 250px; overflow: hidden; margin: 0px;" scrolling="no" marginwidth="0" marginheight="0"></iframe> <a href="https://rtb.adentifi.com/Clicks?crId=477288;sId=760013;lId=100045;cId=18671;adExchange=Rubicon;action=click;adId=6c8725a0-b413-11f0-9211-12126ea64771;adThdId=2e6accf955843ec576534c31d6948918;engineId=i-03fda3c330ecba81f;dIp=MTcyLjU2LjIyMC4xNTM;dIpv6=;adThdIdCode=WEB_MD5_V4;dealId=0;geoId=9837;inventoryId=273233;rtdmIndicator=1;timestamp=1761665596;lat=MC4w;long=MC4w;dma=NTA0;stateCode=;zip=MTkxMDQ;redir=" target="_blank" style="position: absolute; top: 0px; left: 0px; display: inline-block; width: 300px; height: 250px; z-index: 5;"></a> </div></noscript><img src='https://rtb.adentifi.com/Imps?impId=1;adId=6c8725a0-b413-11f0-9211-12126ea64771;lId=100045;sId=760013;cId=18671;crId=477288;adThdId=2e6accf955843ec576534c31d6948918;adExchange=Rubicon;engineId=i-03fda3c330ecba81f;dealId=0;geoId=9837;inventoryId=273233;rtdmIndicator=1;timestamp=1761665596;property=m.imdb.com;dIp=MTcyLjU2LjIyMC4xNTM;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=0;hhId=0;cuid=cuid_954c3b35-8f1d-11f0-9ba7-123a7eade4d1' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_954c3b35-8f1d-11f0-9ba7-123a7eade4d1");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_954c3b35-8f1d-11f0-9ba7-123a7eade4d1&rn=6c8725a0-b413-11f0-9211-12126ea64771' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont477288"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=18671&c=adtheorent01cont477288&w=300&h=250&js=pmw0&plc=tr&uid=2e6accf955843ec576534c31d6948918"></script></span>
</div><div style="height:0px;width:0px;overflow:hidden"><iframe src="https://eus.rubiconproject.com/usync.html?&geo=na&co=us" frameborder="0" marginwidth="0" marginheight="0" scrolling="NO" width="0" height="0" style="height:0px;width:0px"></iframe></div>
Creatives
